HPV vaccination coverage in the European Region

Introduction. Human papillomavirus (HPV) is an established cause of cervical cancer and other HPV-related diseases. This study aims to analyze the variation in coverage by HPV vaccination programs, particularly within the European Region countries, and explore possible health outcomes. Material and methods. A comprehensive literature review and analysis of epidemiological data were conducted, focusing on HPV vaccination coverage rates, the implementation of vaccination programs, and their outcomes across the EU/EEA. The study examined various vaccination models, including school-based and health center-based programs, to understand their effectiveness in achieving high vaccination coverage and the associated reduction in HPV-related disease burden. Results. The study's analysis identified significant variations in HPV vaccination coverage across the EU/EEA. School-based vaccination programs, in particular, were found to be highly effective in reaching the target population, achieving coverage rates significantly higher than those observed in countries relying on health center-based or mixed-model vaccination strategies. Conclusions. HPV vaccination programs have played a crucial role in reducing the burden of HPV-related diseases. These programs' success largely depends on achieving high vaccination coverage, which is more effectively realized through school-based vaccination strategies.